Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

rebel distributors corp - clobetasol propionate (unii: 779619577m) (clobetasol - unii:adn79d536h) - clobetasol propionate 0.5 mg in 1 g - clobetasol propionate cream and ointment are super-high potency corticosteroid formulations indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. treatment beyond 2 consecutive weeks is not recommended, and the total dosage should not exceed 50 g/week because of the potential for the drug to suppress the hypothalamicpituitary- adrenal (hpa) axis. use in pediatric patients under 12 years of age is not recommended. as with other highly active corticosteroids, therapy should be discontinued when control has been achieved. if no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary. clobetasol propionate cream and ointment, usp, 0.05% are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations.

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

merino lanolin skin care products - octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), oxybenzone (unii: 95oos7ve0y) (oxybenzone - unii:95oos7ve0y) - octinoxate 7.5 g in 100 g - helps protect the skin from future sun damage assist your skin's natural moisture retention and elasticity. spf 30 sunscreen helps protect the skin from future sun damage.

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

certus medical, inc. - chloroxylenol (unii: 0f32u78v2q) (chloroxylenol - unii:0f32u78v2q) - chloroxylenol 6 mg in 1 ml - antiseptic for hand-washing to decrease bacteria on  the skin irritation and redness develop

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

allergan, inc. - oxymetazoline hydrochloride (unii: k89mj0s5vy) (oxymetazoline - unii:8vln5b44zy) - oxymetazoline hydrochloride 10 mg in 1 g - rhofade™ cream is indicated for the topical treatment of persistent facial erythema associated with rosacea in adults. none. risk summary there are no available data on rhofade use in pregnant women to inform a drug-associated risk for major birth defects and miscarriage. a literature article describing intranasal decongestant use in pregnant women identified a potential association between second-trimester exposure to oxymetazoline (with no decongestant exposure in the first trimester) and renal collecting system anomalies [ see data ] .  in animal reproduction studies, there were no adverse developmental effects observed after oral administration of oxymetazoline hydrochloride in pregnant rats and rabbits at systemic exposures up to 3 times and 73 times, respectively, the exposure associated with the maximum recommended human dose (mrhd) [see data] .  the estimated background risks of major birth defects and miscarriage for the indicated population are unknown.  all pregnancies have a background risk of bir

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

rochester pharmaceuticals - hydrocortisone acetate (unii: 3x7931po74) (hydrocortisone - unii:wi4x0x7bpj), pramoxine hydrochloride (unii: 88ayb867l5) (pramoxine - unii:068x84e056) - hydrocortisone acetate 10 mg in 1 g - topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. pediatric patients may demonstrate greater susceptibility to topical corticosteroid induced hpa axis suppression and cushing’s syndrome than mature patients because of a larger skin surface area to body weight ratio.  hypothalamic-pituitary-adrenal (hpa) axis suppression, cushing’s syndrome, and intracranial hypertension have been reported in children receiving topical corticosteroids. manifestations of adrenal suppression in children include linear growth retardation, delayed weight gain, low plasma cortisol levels, and absence of response to acth stimulation. manifestations of intracranial hypertension include bulging fontanelles, headaches, and bilateral papilledema.  administration of topical corticosteroids to children should

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

padagis israel pharmaceuticals ltd - permethrin (unii: 509f88p9sz) (permethrin - unii:509f88p9sz) - permethrin 50 mg in 1 g - permethrin cream, 5% is indicated for the treatment of infestation with sarcoptes scabiei (scabies). permethrin cream, 5% is contraindicated in patients with known hypersensitivity to any of its components, to any synthetic pyrethroid or pyrethrin.

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

e. fougera & co., a division of fougera pharmaceuticals inc. - diflorasone diacetate (unii: 7w2j09scwx) (diflorasone - unii:t2dhj9645w) - diflorasone diacetate 0.5 mg in 1 g - diflorasone diacetate cream usp, 0.05% is a high potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. diflorasone diacetate cream is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

patchwerx labs, inc. - menthol 0.44% zinc oxide 20.6% - tretinoin gel and cream are indicated for topical application in the treatment of acne vulgaris. the safety and efficacy of the long-term use of this product in the treatment of other disorders have not been established. use of the product should be discontinued if hypersensitivity to any of the ingredients is noted. external analgesic / anti-itch skin protectant / anorectal astringent a moisture barrier that prevents and helps heal skin irritation from: urine, diarrhea, perspiration, fistula damage, feeding tube site leakage, wound drainage (peri-wound skin), minor burns, cuts, scrapes, itching

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

direct rx - hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - the topical steroids constitute a class of primarily synthetic steroids used as anti-inflammatory and antipruritic agents. hydrocortisone is a member of this class. hydrocortisone has the chemical name pregn-4-ene-3,20-dione, 11,17,21- trihydroxy-, (11β)-. its molecular formula is c21h30o5 and molecular weight 362.47. structural formula is: hydrocortisone cream usp, 1% (each gram contains 10 mg of hydrocortisone); 2.5% (each gram contains 25 mg of hydrocortisone); in a base containing purified water, propylene glycol, propylene glycol monostearate, mineral oil and lanolin alcohol, isopropyl palmitate, polysorbate 60, cetyl alcohol, sorbitan monostearate, polyoxyl 40 stearate, sorbic acid, methylparaben and propylparaben. topical corticosteroids are indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

teligent pharma, inc. - clobetasol propionate (unii: 779619577m) (clobetasol - unii:adn79d536h) - clobetasol propionate cream is a  super-high potency corticosteroid formulation indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. treatment beyond 2 consecutive weeks is not recommended, and the total dosage should not exceed 50 g/week because of the potential for the drug to suppress the hypothalamicpituitary- adrenal (hpa) axis. use in pediatric patients under 12 years of age is not recommended. as with other highly active corticosteroids, therapy should be discontinued when control has been achieved. if no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary. clobetasol propionate cream, usp, 0.05% is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations.